ConductScience.org, home

Paper855997

Cefoxitin: clinical evaluation in thirty-eight patients.

Heseltine PN and 3 others. Antimicrob Agents Chemother, 1977. Cited by 49 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cefoxitin: clinical evaluation in thirty-eight patients. Papers, record 855997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/855997

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cefoxitin: clinical evaluation in thirty-eight patients.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
3.36
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heseltine PNP N
2Busch DFD F
3Meyer RDR D
4Finegold SMS M

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial InfectionsMajor topic
CefoxitinMajor topic
CephalosporinsMajor topic
Adult
Aged
Drug Evaluation
Female
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Peritonitis
Pneumonia
Urinary Tract Infections

Source PubMed

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,830,485Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15830485PubMed
215,830,475Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15830475PubMed
315,828,188Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828188PubMed
44,202,265Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.Br Med J1973https://conductscience.org/library/papers/4202265PubMed
54,599,124Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4599124PubMed
65,053Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/5053PubMed
74,840,447Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4840447PubMed
84,790,596Cephalosporinase activity in Bacteroides fragilis.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790596PubMed
94,791,486Clinical studies of cefazolin and comparison with other cephalosporins.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4791486PubMed
104,915,151The cephalosporins. Microbiological, chemical, and pharmacological properties and use in chemotherapy of infection.Ann Intern Med1970https://conductscience.org/library/papers/4915151PubMed
11804,023Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.J Infect Dis1975https://conductscience.org/library/papers/804023PubMed
12949,175Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/949175PubMed
131,263,595The in vitro spectrum of the cephalosporins.Mayo Clin Proc1976https://conductscience.org/library/papers/1263595PubMed
141,267,443Comparison of phlebitis produced by cephapirin and cephalothin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1267443PubMed
151,244,540Letter: Best's biliary flush.N Engl J Med1976https://conductscience.org/library/papers/1244540PubMed
161,137,364Susceptibility of anaerobes to cefoxitin and other cephalosporins.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1137364PubMed

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
36,175,707
Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study.
Ann Intensive Care2022https://conductscience.org/library/papers/36175707PubMed
7,396,456Clinical and pharmacokinetic evaluation of parental cefoxitin in infants and children.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7396456PubMed
7,103,449Penetration of cefoxitin into cerebrospinal fluid of infants and children with bacterial meningitis.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7103449PubMed
6,372,916Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?Bull N Y Acad Med1984https://conductscience.org/library/papers/6372916PubMed
6,360,636Antimicrobial drugs used in the management of anaerobic infections in children.Drugs1983https://conductscience.org/library/papers/6360636PubMed
3,319,501Treatment of respiratory tract infections with cephalosporin antibiotics.Drugs1987https://conductscience.org/library/papers/3319501PubMed
3,045,147Susceptibility testing of anaerobic bacteria.J Clin Microbiol1988https://conductscience.org/library/papers/3045147PubMed
2,327,757Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2327757PubMed
1,295,755Clinical relevance of antimicrobial susceptibility testing.Eur J Clin Microbiol Infect Dis1992https://conductscience.org/library/papers/1295755PubMed
507,792Anaerobic infection in cancer patients: comparative evaluation of clindamycin and cefoxitin.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/507792PubMed
485,129Clinical and bacteriological evaluation of cefoxitin therapy in children.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/485129PubMed
369,806Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs1979https://conductscience.org/library/papers/369806PubMed
348,096Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/348096PubMed
335,968Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/335968PubMed
122,524Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/122524PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/855997

GET https://conductscience.org/api/papers/v1/855997/authors